ELEV
Price
$0.51
Change
-$0.01 (-1.92%)
Updated
Mar 3, 12:12 PM (EDT)
Capitalization
30.97M
2 days until earnings call
ONPPF
Price
$0.27
Change
-$0.34 (-56.67%)
Updated
May 3 closing price
Capitalization
31.24M
Ad is loading...

ELEV vs ONPPF

Header iconELEV vs ONPPF Comparison
Open Charts ELEV vs ONPPFBanner chart's image
Elevation Oncology
Price$0.51
Change-$0.01 (-1.92%)
Volume$2K
Capitalization30.97M
ONCOPEPTIDES AB
Price$0.27
Change-$0.34 (-56.67%)
Volume$200
Capitalization31.24M
ELEV vs ONPPF Comparison Chart
Loading...
ELEV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELEV vs. ONPPF commentary
Mar 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELEV is a Hold and ONPPF is a Buy.

Ad is loading...
COMPARISON
Comparison
Mar 03, 2025
Stock price -- (ELEV: $0.52 vs. ONPPF: $0.26)
Brand notoriety: ELEV and ONPPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELEV: 34% vs. ONPPF: 100%
Market capitalization -- ELEV: $30.97M vs. ONPPF: $31.24M
ELEV [@Biotechnology] is valued at $30.97M. ONPPF’s [@Biotechnology] market capitalization is $31.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $398.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.49B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELEV’s FA Score shows that 1 FA rating(s) are green whileONPPF’s FA Score has 0 green FA rating(s).

  • ELEV’s FA Score: 1 green, 4 red.
  • ONPPF’s FA Score: 0 green, 5 red.
According to our system of comparison, ELEV is a better buy in the long-term than ONPPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELEV’s TA Score shows that 4 TA indicator(s) are bullish.

  • ELEV’s TA Score: 4 bullish, 6 bearish.

Price Growth

ELEV (@Biotechnology) experienced а -13.75% price change this week, while ONPPF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.17%. For the same industry, the average monthly price growth was -7.58%, and the average quarterly price growth was -2.62%.

Reported Earning Dates

ELEV is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-3.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ONPPF($31.2M) and ELEV($31M) have the same market capitalization . ONPPF YTD gains are higher at: 0.000 vs. ELEV (-6.879). ELEV has higher annual earnings (EBITDA): -43.11M vs. ONPPF (-270.36M). ONPPF has more cash in the bank: 250M vs. ELEV (103M). ELEV has less debt than ONPPF: ELEV (31M) vs ONPPF (117M). ONPPF has higher revenues than ELEV: ONPPF (27.1M) vs ELEV (0).
ELEVONPPFELEV / ONPPF
Capitalization31M31.2M99%
EBITDA-43.11M-270.36M16%
Gain YTD-6.8790.000-
P/E RatioN/AN/A-
Revenue027.1M-
Total Cash103M250M41%
Total Debt31M117M26%
TECHNICAL ANALYSIS
Technical Analysis
ELEV
RSI
ODDS (%)
Bullish Trend 4 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 14 days ago
87%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
78%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
ELEV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TGTX30.091.56
+5.47%
TG Therapeutics
ALC92.500.53
+0.58%
Alcon
SAFT76.140.08
+0.11%
Safety Insurance Group
INDO2.70N/A
N/A
Indonesia Energy Corp
NEWT12.99-0.03
-0.23%
NewtekOne

ONPPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONPPF has been loosely correlated with IPHYF. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ONPPF jumps, then IPHYF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONPPF
1D Price
Change %
ONPPF100%
N/A
IPHYF - ONPPF
41%
Loosely correlated
N/A
AEON - ONPPF
39%
Loosely correlated
-11.76%
OTLK - ONPPF
20%
Poorly correlated
+8.70%
CRDF - ONPPF
20%
Poorly correlated
+4.43%
ELEV - ONPPF
2%
Poorly correlated
+1.71%
More